LYNPARZA

astrazeneca canada inc🇨🇦 Health Canada

Approval Id: 13c9ab9e14eb8918
Drug Approval Canada Name: LYNPARZA
Product Name: LYNPARZA
Status: Cancelled Post Market
Status Date: 2021-01-11
Original Market Date: 2016-05-16
Din: 02454408
Drug Class: Human
Dosage Form: Capsule
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XK01 OLAPARIB
Atc Name: l 01 xk 01
Aig Number: 0158110001
Company Name: astrazeneca canada inc
Company Address: 1004 Middlegate Road, Suite 5000, Mississauga, Ontario, Canada, L4Y 1M4

OLAPARIB

50 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

13c9ab9e14eb8918

Type

Standard